Do Preoperative Esophageal pH Monitoring and High-Resolution Manometry Predict Symptoms of GERD After Sleeve Gastrectomy?
24-h pH monitoring
Dietary habits
Gastroesophageal reflux disease
High-resolution esophageal manometry
Sleeve gastrectomy
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
07
12
2020
accepted:
13
04
2021
revised:
08
04
2021
pubmed:
21
4
2021
medline:
21
7
2021
entrez:
20
4
2021
Statut:
ppublish
Résumé
Predictive factors of evolution or appearance of gastroesophageal reflux disease (GERD) after sleeve gastrectomy (SG) have not been identified to date. We aimed to assess the evolution of GERD symptoms 1 year after SG and to determine preoperative predictive factors using high-resolution manometry (HRM) and ambulatory 24-h esophageal pH monitoring (APM). We included 160 patients who underwent SG between 2013 and 2017 and performed preoperative APM and HRM. Positive APM was defined according to the Lyon consensus. Symptoms of GERD, proton pump inhibitors (PPI) use, weight loss (WL), and diet were recorded in all patients before and 1 year after surgery. One year after surgery, 58 patients (36.3%) complained of GERD symptoms compared to 52 patients (32.5%) preoperatively (p=0.48). Among patients with preoperative GERD symptoms, only 26/52 patients (50%) still had symptoms, whereas 32/108 (29.6%) asymptomatic patients developed de novo GERD symptoms after surgery. PPI use increased after surgery reaching 36.9% of patients against 15.0% before (p<0.0001). Only preoperative symptoms of GERD were predictive of postoperative symptoms (OR= 2.47 [1.14-5.45]; p=0.023) in multivariate analysis. Preoperative manometric parameters, postoperative diet, and WL were not related to postoperative symptoms. In asymptomatic patients before surgery, silent GERD (positive APM without symptom) was predictive of postoperative GERD symptoms (OR=2.69 [1.00-7.25]; p=0.049). Evolution of GERD symptoms after SG reveals improvement for half of the patients and de novo GERD symptoms in one-third of patients. Predictive factors of postoperative symptoms are preoperative symptoms and positive preoperative APM in asymptomatic patients.
Sections du résumé
BACKGROUND
Predictive factors of evolution or appearance of gastroesophageal reflux disease (GERD) after sleeve gastrectomy (SG) have not been identified to date. We aimed to assess the evolution of GERD symptoms 1 year after SG and to determine preoperative predictive factors using high-resolution manometry (HRM) and ambulatory 24-h esophageal pH monitoring (APM).
METHODS
We included 160 patients who underwent SG between 2013 and 2017 and performed preoperative APM and HRM. Positive APM was defined according to the Lyon consensus. Symptoms of GERD, proton pump inhibitors (PPI) use, weight loss (WL), and diet were recorded in all patients before and 1 year after surgery.
RESULTS
One year after surgery, 58 patients (36.3%) complained of GERD symptoms compared to 52 patients (32.5%) preoperatively (p=0.48). Among patients with preoperative GERD symptoms, only 26/52 patients (50%) still had symptoms, whereas 32/108 (29.6%) asymptomatic patients developed de novo GERD symptoms after surgery. PPI use increased after surgery reaching 36.9% of patients against 15.0% before (p<0.0001). Only preoperative symptoms of GERD were predictive of postoperative symptoms (OR= 2.47 [1.14-5.45]; p=0.023) in multivariate analysis. Preoperative manometric parameters, postoperative diet, and WL were not related to postoperative symptoms. In asymptomatic patients before surgery, silent GERD (positive APM without symptom) was predictive of postoperative GERD symptoms (OR=2.69 [1.00-7.25]; p=0.049).
CONCLUSION
Evolution of GERD symptoms after SG reveals improvement for half of the patients and de novo GERD symptoms in one-third of patients. Predictive factors of postoperative symptoms are preoperative symptoms and positive preoperative APM in asymptomatic patients.
Identifiants
pubmed: 33877508
doi: 10.1007/s11695-021-05427-5
pii: 10.1007/s11695-021-05427-5
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3490-3497Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199–211.
doi: 10.7326/0003-4819-143-3-200508020-00006
Suter M, Dorta G, Giusti V, et al. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients. Obes Surg. 2004;14(7):959–66.
doi: 10.1381/0960892041719581
Chang P, Friedenberg F. Obesity & GERD. Gastroenterol Clin N Am. 2014;43(1):161–73.
doi: 10.1016/j.gtc.2013.11.009
Ortiz V, Ponce M, Fernández A, et al. Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients. Obes Silver Spring Md. 2006;14(4):696–700.
doi: 10.1038/oby.2006.79
Ortiz V, Alvarez-Sotomayor D, Sáez-González E, et al. Decreased esophageal sensitivity to acid in morbidly obese patients: a cause for concern? Gut Liver. 2017;11(3):358–62.
doi: 10.5009/gnl16081
Stein DJ, El-Serag HB, Kuczynski J, et al. The association of body mass index with Barrett’s oesophagus. Aliment Pharmacol Ther. 2005;22(10):1005–10.
doi: 10.1111/j.1365-2036.2005.02674.x
Edelstein ZR, Farrow DC, Bronner MP, et al. Central adiposity and risk of Barrett’s esophagus. Gastroenterology. 2007;133(2):403–11.
doi: 10.1053/j.gastro.2007.05.026
Singh S, Sharma AN, Murad MH, et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(11):1399–1412.e7.
doi: 10.1016/j.cgh.2013.05.009
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO Worldwide Survey 2014. Obes Surg. 2017;27(9):2279–89.
doi: 10.1007/s11695-017-2666-x
Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65.
doi: 10.1001/jama.2017.20897
Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS Randomized Clinical Trial. JAMA. 2018 Jan 16;319(3):241–54.
doi: 10.1001/jama.2017.20313
Khan A, Kim A, Sanossian C, et al. Impact of obesity treatment on gastroesophageal reflux disease. World J Gastroenterol. 2016;22(4):1627–38.
doi: 10.3748/wjg.v22.i4.1627
Gu L, Chen B, Du N, et al. Relationship between bariatric surgery and gastroesophageal reflux disease: a systematic review and meta-analysis. Obes Surg. 2019;29(12):4105–13.
doi: 10.1007/s11695-019-04218-3
Himpens J, Dobbeleir J, Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann Surg. 2010;252(2):319–24.
doi: 10.1097/SLA.0b013e3181e90b31
DuPree CE, Blair K, Steele SR, et al. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis. JAMA Surg. 2014;149(4):328–34.
doi: 10.1001/jamasurg.2013.4323
Arman GA, Himpens J, Dhaenens J, et al. Long-term (11+years) outcomes in weight, patient satisfaction, comorbidities, and gastroesophageal reflux treatment after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2016;12(10):1778–86.
doi: 10.1016/j.soard.2016.01.013
Pallati PK, Shaligram A, Shostrom VK, et al. Improvement in gastroesophageal reflux disease symptoms after various bariatric procedures: review of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2014;10(3):502–7.
doi: 10.1016/j.soard.2013.07.018
Pilone V, Tramontano S, Renzulli M, et al. Gastroesophageal reflux after sleeve gastrectomy: new onset and effect on symptoms on a prospective evaluation. Obes Surg. 2019 Nov;29(11):3638–45.
doi: 10.1007/s11695-019-04046-5
Yeung KTD, Penney N, Ashrafian L, et al. Does sleeve gastrectomy expose the distal esophagus to severe reflux?: a systematic review and meta-analysis. Ann Surg. 2020;271(2):257–65.
doi: 10.1097/SLA.0000000000003275
Rebecchi F, Allaix ME, Giaccone C, et al. Gastroesophageal reflux disease and laparoscopic sleeve gastrectomy: a physiopathologic evaluation. Ann Surg. 2014 Nov;260(5):909–15.
doi: 10.1097/SLA.0000000000000967
Thereaux J, Lesuffleur T, Czernichow S, et al. Do sleeve gastrectomy and gastric bypass influence treatment with proton pump inhibitors four years after surgery? A nationwide cohort. Surg Obes Relat Dis. 2016;1:13.
Coupaye M, Gorbatchef C, Calabrese D, et al. Gastroesophageal reflux after sleeve gastrectomy: a prospective mechanistic study. Obes Surg. 2018;28(3):838–45.
doi: 10.1007/s11695-017-2942-9
Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc. 2015;27(2):160–74.
doi: 10.1111/nmo.12477
Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67(7):1351–62.
doi: 10.1136/gutjnl-2017-314722
Johnson LF, DeMeester TR. Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol. 1986;8(Suppl 1):52–8.
doi: 10.1097/00004836-198606001-00008
Ferrer-Márquez M, Belda-Lozano R, Ferrer-Ayza M. Technical controversies in laparoscopic sleeve gastrectomy. Obes Surg. 2012;22(1):182–7.
doi: 10.1007/s11695-011-0492-0
Oor JE, Roks DJ, Ünlü Ç, et al. Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Surg. 2016;211(1):250–67.
doi: 10.1016/j.amjsurg.2015.05.031
Howard DD, Caban AM, Cendan JC, et al. Gastroesophageal reflux after sleeve gastrectomy in morbidly obese patients. Surg Obes Relat Dis. 2011;7(6):709–13.
doi: 10.1016/j.soard.2011.08.003
Kavanagh R, Smith J, Bashir U, et al. Optimizing bariatric surgery outcomes: a novel preoperative protocol in a bariatric population with gastroesophageal reflux disease. Surg Endosc. 2019;25
Kristo I, Paireder M, Jomrich G, et al. Silent gastroesophageal reflux disease in patients with morbid obesity prior to primary metabolic surgery. Obes Surg [Internet]. 2020 [cited 2020 Nov 24];30:4885–91. https://doi.org/10.1007/s11695-020-04959-6 .
doi: 10.1007/s11695-020-04959-6
Borbély Y, Schaffner E, Zimmermann L, et al. De novo gastroesophageal reflux disease after sleeve gastrectomy: role of preoperative silent reflux. Surg Endosc. 2019 Mar;33(3):789–93.
doi: 10.1007/s00464-018-6344-4
Stino AM, Smith AG. Peripheral neuropathy in prediabetes and the metabolic syndrome. J Diabetes Investig. 2017 Sep;8(5):646–55.
doi: 10.1111/jdi.12650
Tolone S, Savarino E, de Bortoli N, et al. Esophageal high-resolution manometry can unravel the mechanisms by which different bariatric techniques produce different reflux exposures. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2020;24(1):1–7.
doi: 10.1007/s11605-019-04406-7
Quero G, Fiorillo C, Dallemagne B, et al. The causes of gastroesophageal reflux after laparoscopic sleeve gastrectomy: quantitative assessment of the structure and function of the esophagogastric junction by magnetic resonance imaging and high-resolution manometry. Obes Surg. 2020;30(6):2108–17.
doi: 10.1007/s11695-020-04438-y
Chern TY, Chan DL, Maani J, Ferguson JS, Talbot ML. High-resolution impedance manometry and 24-hour multichannel intraluminal impedance with pH testing before and after sleeve gastrectomy: de novo reflux in a prospective series. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2020 23;
Greilsamer T, de Montrichard M, Bruley des Varannes S, Jacobi D, Guillouche M, Regenet N, et al. Hypotonic low esophageal sphincter is not predictive of gastroesophageal reflux disease after sleeve gastrectomy. Obes Surg. 2020;
Navarini D, Madalosso CAS, Tognon AP, Fornari F, Barão FR, Gurski RR. Predictive factors of gastroesophageal reflux disease in bariatric surgery: a controlled trial comparing sleeve gastrectomy with gastric bypass. Obes Surg. 2020;
Yamamichi N, Mochizuki S, Asada-Hirayama I, et al. Lifestyle factors affecting gastroesophageal reflux disease symptoms: a cross-sectional study of healthy 19864 adults using FSSG scores. BMC Med. 2012;10:45.
doi: 10.1186/1741-7015-10-45
Soricelli E, Casella G, Baglio G, et al. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy. Surg Obes Relat Dis. 2018;14(6):751–6.
doi: 10.1016/j.soard.2018.02.008